These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8544420

  • 1. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C.
    Kidney Int; 1995 Nov; 48(5):1600-4. PubMed ID: 8544420
    [Abstract] [Full Text] [Related]

  • 2. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 4. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M, Grcevska L, Dzikova S.
    Prilozi; 2006 Dec 05; 27(2):5-12. PubMed ID: 17211287
    [Abstract] [Full Text] [Related]

  • 5. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 6. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T.
    N Engl J Med; 1984 Apr 12; 310(15):946-50. PubMed ID: 6366560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 12. Idiopathic membranous nephropathy in the elderly.
    Passerini P, Como G, Viganò E, Melis P, Pozzi C, Altieri P, Ponticelli C.
    Nephrol Dial Transplant; 1993 Sep 01; 8(12):1321-5. PubMed ID: 8159299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
    Howman A, Chapman TL, Langdon MM, Ferguson C, Adu D, Feehally J, Gaskin GJ, Jayne DR, O'Donoghue D, Boulton-Jones M, Mathieson PW.
    Lancet; 2013 Mar 02; 381(9868):744-51. PubMed ID: 23312808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M.
    Kidney Int; 2002 Jan 02; 61(1):219-27. PubMed ID: 11786104
    [Abstract] [Full Text] [Related]

  • 17. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 02; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The advantages of immunosuppressive therapy in renal disease.
    Zucchelli P.
    Ann Med Interne (Paris); 1988 Feb 02; 139(2):108-11. PubMed ID: 3293499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.